Safic-Alcan expands in India with majority stake in SA Ingredients
The deal brings SAI — a key distributor serving pharmaceutical and nutraceutical manufacturers — into the Safic-Alcan Group’s expanding Asia footprint
The deal brings SAI — a key distributor serving pharmaceutical and nutraceutical manufacturers — into the Safic-Alcan Group’s expanding Asia footprint
Approval strengthens the company’s growing international anti-infective portfolio
Supported by Plan International, the partnership will help treat over 1,000 children annually
Company handles 20,000+ AI-driven calls and chats daily as it scales agentic AI systems across healthcare workflows
With 267 million tobacco users, improving access to evidence-based cessation tools is seen as critical
The initiative by DKMS Foundation India is for below 12 years children suffering from transfusion-dependent thalassemia
The formulation contains 0.075% Capsaicin, a clinically proven ingredient along with menthol, camphor and eucalyptus oil
This is an exciting and meaningful milestone for GRIN Therapeutics
At the center of the deal is TERN-701, a drug recently granted Breakthrough Therapy Designation by the U.S. Food and Drug Administration for adults with Philadelphia chromosome-positive chronic myeloid leukemia
The standout story remains Wegovy, particularly its new oral formulation
Subscribe To Our Newsletter & Stay Updated